Quantification of insulin-like growth factor I (IGF-I) without interference by IGF binding proteins

Area of Science:

• Biochemistry
• Cell Biology
• Assay Development

Background:

• Insulin-like Growth Factor-I (IGF-I) is crucial for cell growth and differentiation.
• Accurate measurement of IGF-I in cell culture is essential for research.
• Existing methods like radioimmunoassays (RIAs) can be affected by IGF binding proteins (IGFBPs).

Purpose of the Study:

• To develop a rapid and reliable assay for quantifying IGF-I in serum-free conditioned media (CM).
• To evaluate the interference of IGFBPs in the developed assay compared to RIAs.

Main Methods:

• Development of a chemiluminescent dot blot assay for IGF-I detection.
• Testing the interference of all six IGFBPs on the dot blot assay.
• Comparison of IGF-I detection with a standard RIA using the same monoclonal antibody.
• Quantification of chemiluminescence using phosphorimager and Molecular Analyst software.

Main Results:

• The chemiluminescent dot blot assay successfully detected IGF-I in CM without interference from IGFBPs.
• All six IGFBPs bound to 125I IGF-I but did not interfere with detection on dot blots.
• A comparable RIA showed interference from IGFBP-1, IGFBP-2, and IGFBP-4.
• The dot blot assay demonstrated sensitivity (0.125-8.0 ng/mL), specificity (<1% cross-reactivity with IGF-II), and reproducibility (intra-assay variance ≤6%, inter-assay variance <12%).

Conclusions:

• The developed chemiluminescent dot blot assay provides a robust, sensitive, and specific method for IGF-I quantification in serum-free CM.
• This assay overcomes the limitations of RIAs by eliminating IGFBP interference.
• The assay is not suitable for serum or serum-containing media due to reagent sensitivity to serum components.